Deferasirox - a rarer cause of Fanconi syndrome

• Главные авторы: Iman Khan (Автор), Mustafa Muhammad (Автор), Janki Patel (Автор)
• Формат: ‌
• Опубликовано: Greater Baltimore Medical Center, 2019-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Deferasirox is a recently approved iron chelator and is widely used to treat iron overload in transfusion-dependent patients. Its once-daily dosing and oral route of administration have made it an appealing alternative to deferoxamine. Recent case studies have brought to light its potential to cause...